Regulate logo

  • Facebook
  • Twitter

Regulate menu

Supplying sodium valproate safely to women and girls

25 July 2019

All members of the pharmacy team should make sure they follow the MHRA’s Pregnancy Prevention Programme (PPP) for sodium valproate every time it is dispensed. 

We spoke to two women whose children were affected by exposure to sodium valproate during their pregnancies, to find out why it’s so important to make sure that women are made aware of the risks when dispensing sodium valproate.

See the previous Regulate article on dispensing sodium valproate safely
 

Related articles

11 December 2019
We have published the findings of our second major survey, which asked pharmacists and pharmacy technicians about their roles and responsibilities, work settings, employment and practice and future...
11 December 2019
By now, some of you will have successfully submitted your first reflective account alongside your other revalidation records. Depending on when you joined the register, you may be submitting your...
11 December 2019
The GPhC’s governing council has agreed new education and training requirements and learning outcomes for all pharmacy support roles. The Council decided to introduce the new requirements after...
19 September 2019
We’ve published an updated version of our publication and disclosure policy [PDF 831 KB] which sets out what information we publish on our website, how we deal with individual requests for...
29 July 2019
A pharmacy professional’s religion, personal values and beliefs can play an important part in their life and make a positive contribution to their work and the care they provide. However, in some...